-transparent.png){kind=logo}
The infrared and mass spectra of N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA) and 1-(3,4-methylenedioxyphenyl)-2-butanamine are quite similar. These two compounds differ only in the position of substitution of a single methyl group. MDMA is a controlled street drug known as Ecstasy, while the isomeric butanamine is a member of a new class of potential psychotherapeutic agents called entactogens. These two compounds produce similar mass spectral fragmentation patterns including a common base peak at m/z 58. Reversed-phase liquid chromatographic (RPLC) methods consisting of a C18 stationary phase and an aqueous scidic mobile phase were used to separate these two compounds. Thus, LC methods can be used to differentiate MDMA from the isomeric butanamine for forensic analysis.
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
October 1996,
Journal of analytical toxicology,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
November 2005,
Pharmacology, biochemistry, and behavior,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
March 2007,
Pharmacology, biochemistry, and behavior,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
August 1989,
Pharmacology, biochemistry, and behavior,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
September 2008,
Journal of forensic sciences,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
January 1998,
Rapid communications in mass spectrometry : RCM,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
September 2015,
Bioorganic & medicinal chemistry,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
March 2002,
Journal of analytical toxicology,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
May 2005,
Forensic science international,
F T Noggle, and
C R Clark, and
S Andurkar, and
J DeRuiter
December 1992,
Pharmacology, biochemistry, and behavior,
